Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2020-10-20 Board/Management Inform…
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 20, 2020, by Praxis Precision Medicines, Inc. It reports amendments to the Articles of Incorporation and Bylaws, including the filing of an amended and restated certificate of incorporation and amended and restated bylaws. The document includes descriptions of these amendments and references exhibits containing the full text of the amended documents. There are no financial statements or earnings data presented, nor is this a report of financial results or management discussion. The content focuses on corporate governance changes, specifically amendments to foundational corporate documents. This fits the category of Board/Management Information (MANG), which includes announcements of changes in company governance documents and board-related matters. The document is not a full annual or quarterly report, nor is it a proxy statement or voting results announcement. Therefore, the best classification is MANG with high confidence.
2020-10-20 English
FORM S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans and employee stock purchase plans. It includes detailed information about the securities to be registered, the plans under which they are offered, and legal indemnification provisions. This type of filing is related to share issuance and capital changes, specifically concerning employee stock plans. It is not an annual report, earnings release, or any other financial report but a registration statement for securities issuance. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is the actual registration statement, not just an announcement or certification.
2020-10-16 English
424B4
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for an initial public offering (IPO) of common stock by Praxis Precision Medicines, Inc. It includes extensive information such as the offering details, risk factors, use of proceeds, dividend policy, capitalization, dilution, consolidated financial data, management discussion and analysis, business overview, management and executive compensation, principal stockholders, description of capital stock, underwriting details, legal matters, and the report of independent registered public accounting firm. The document is filed pursuant to Rule 424(b)(4), which is a prospectus filing related to securities offerings. This type of document is a capital markets filing related to financing activities and capital structure changes, specifically an IPO prospectus. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is not a brief announcement or a regulatory filing but a substantive financing document.
2020-10-16 English
Regulatory Filings 2020
Regulatory Filings
2020-10-16 English
FORM 3 SUBMISSION
Director's Dealing
2020-10-16 English
FORM 3 SUBMISSION
Director's Dealing
2020-10-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.